Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the effects of thiorphan, a specific inhibitor of enkephalinase A and bestatin, a specific inhibitor of aminopeptidase, on the stereotyped behaviors induced by phencyclidine (
PCP
) in cannulated rats. The
PCP
-induced turning was significantly potentiated when thiorphan (50 micrograms) and bestatin (50 micrograms) were injected simultaneously into the rat lateral ventricle. The increase of
PCP
-induced turning was completely antagonized by the pretreatment with naloxone.
Thiorphan
(50 micrograms) or bestatin (50 micrograms) alone failed to potentiate
PCP
-induced turning.
Thiorphan
and/or bestatin did not affect significantly the
PCP
-induced head weaving and back-pedalling except that thiorphan (50 micrograms) potentiated the
PCP
-induced head weaving 15-18 min after the
PCP
injection. The combination of thiorphan and bestatin alone did not induce any behavioral change. These results suggest that thiorphan and bestatin produce an increase of endogenous enkephalins and that as a result,
PCP
-induced turning may be enhanced.
...
PMID:Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin. 345 6